Focus Partners Wealth Purchases 1,290,833 Shares of The Cooper Companies, Inc. $COO

Focus Partners Wealth lifted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 39,754.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,294,080 shares of the medical device company’s stock after acquiring an additional 1,290,833 shares during the period. Focus Partners Wealth owned approximately 0.66% of Cooper Companies worth $106,063,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Aurora Investment Counsel increased its position in shares of Cooper Companies by 8.1% during the fourth quarter. Aurora Investment Counsel now owns 22,381 shares of the medical device company’s stock valued at $1,834,000 after acquiring an additional 1,683 shares in the last quarter. Brown Advisory Inc. bought a new stake in shares of Cooper Companies during the fourth quarter valued at approximately $8,287,000. Arrowstreet Capital Limited Partnership increased its position in shares of Cooper Companies by 214.7% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 2,108,698 shares of the medical device company’s stock valued at $172,829,000 after acquiring an additional 1,438,702 shares in the last quarter. Kestra Advisory Services LLC increased its position in shares of Cooper Companies by 145.7% during the fourth quarter. Kestra Advisory Services LLC now owns 8,438 shares of the medical device company’s stock valued at $692,000 after acquiring an additional 5,004 shares in the last quarter. Finally, Boyar Asset Management Inc. bought a new stake in shares of Cooper Companies during the fourth quarter valued at approximately $660,000. Institutional investors own 24.39% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the stock. Barclays raised their price target on shares of Cooper Companies from $98.00 to $103.00 and gave the company an “overweight” rating in a research report on Friday, March 6th. KeyCorp reissued a “sector weight” rating on shares of Cooper Companies in a research report on Friday, June 5th. Weiss Ratings downgraded shares of Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research report on Monday, June 8th. JPMorgan Chase & Co. reduced their price target on shares of Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a research report on Friday, June 5th. Finally, Wells Fargo & Company reaffirmed a “sell” rating and issued a $66.00 target price (down from $82.00) on shares of Cooper Companies in a research report on Friday, June 5th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, five have given a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat, Cooper Companies has an average rating of “Hold” and a consensus target price of $82.64.

Cooper Companies Stock Performance

NASDAQ:COO opened at $67.88 on Monday. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23. The Cooper Companies, Inc. has a 12 month low of $58.89 and a 12 month high of $89.83. The company has a market cap of $13.24 billion, a PE ratio of 57.53, a price-to-earnings-growth ratio of 1.78 and a beta of 0.88. The company has a 50 day simple moving average of $64.79 and a two-hundred day simple moving average of $74.34.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The business had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. During the same quarter in the previous year, the firm posted $0.96 EPS. The firm’s revenue was up 7.9% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Research analysts forecast that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.